Intranasal administration of peptides has been shown effective due to the following factors [27]: Large surface area Permeable endothelial membrane Elimination of first-pass effect Good circulation Researchers who wish to administer the BPC-157 and TB-500 blend via a nasal spray are encouraged to take certain precautions to ensure delivery of maximum bioavailability: To optimize absorption: Wait up to one minute between sprays via the same nostril to prevent oversaturating the nasal membrane and thus losing peptide due to swallowing
El-Kenawi A, Gatenbee C, Robertson-Tessi M, Bravo R, Dhillon J, Balagurunathan Y, et al
Or worse, contaminants could cause their own unforeseen biological effects, completely ruining the data
Steve Gardner, Chief Executive Officer of PrecisionLife, added: This is our first collaboration with Ovation, giving us access to world-class multiomic and clinical data to expand our proven capability in identifying drug-response biomarkers beyond clinical trials and into real-world healthcare
Administered via intramuscular or subcutaneous injection